TipRanks
Go Ultimate55% OFF

Mettler-Toledo (MTO) AI Stock Analysis

DE:MTO

Mettler-Toledo

(XETRA:MTO)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong, stable profitabilityHigh and fairly stable margins indicate meaningful pricing power and operational discipline across the business. This profitability provides resources to fund product innovation, absorb moderate cost pressure, and convert improving revenue into durable earnings over the next several quarters.
Negative Factors
Meaningful leverage and volatile equityMeaningful debt and a history of negative or very low equity reduce balance-sheet flexibility despite strong earnings. This structure can constrain capital allocation, make equity-based leverage measures unstable, and leave less financial room during weaker demand or higher-cost periods.

Mettler-Toledo (MTO) vs. iShares MSCI Germany ETF (EWG)

-30%-20%-10%0%10%20%30%DE:MTO+22.02%EWG+6.61%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 33.63B
Dividend Yield
―
Average Volume (3M)
3
Price to Earnings (P/E)
37.7
Beta (1Y)
0.72
Revenue Growth
-0.31%
EPS Growth
4.88%
Country
Germany
Employees
16,600
Sector
Healthcare
Sector Strength
51
Industry
Medical - Diagnostics & Research

Mettler-Toledo Business Overview & Revenue Model

Company Description

Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domes...

Mettler-Toledo Earnings Call Summary

Earnings Call Date:Jul 29, 2026(Q2-2026)|% Change Since:26.28%|Next Earnings Date:Nov 04, 2026
Earnings Call SentimentPositive

The call conveyed a decidedly positive operational and financial picture: revenue growth beat expectations, margins expanded, adjusted EPS rose ~14% and full-year guidance was raised. Strength was broad-based (China, emerging markets, Lab, Industrial automation, services) and driven by pricing, productivity initiatives (Spinnaker) and product innovation. Notable risks and noise included one-time tariff refund accounting that reduced reported sales, timing-related weakness in Product Inspection and certain projects, EU chemical exposure to energy costs, higher transportation costs, and short backlog that increases near-term sensitivity. On balance, management presented confidence in execution and raised guidance, indicating momentum into the second half despite identifiable near-term risks.

Positive Updates

Top-Line Growth Outperformed Expectations
Q2 sales were $1.0B, up 7% in USD and 6% in local currency; organic local-currency sales growth was 4% and acquisitions contributed ~1.5%.

Negative Updates

Tariff Refunds Created One-Time Accounting Noise and Reduced Reported Sales
A one-time gross benefit of $52M from IEEPA tariff refunds benefited cost of sales but was partially offset by a $28M refund to customers that reduced reported net sales by ~3%; the company excludes these items from adjusted results.

Company Guidance

The company raised its full‑year 2026 guidance, now calling for local‑currency sales growth of approximately 4%–5% (organic 3%–4%) excluding the one‑time tariff refunds, with adjusted EPS guidance of $47.15–$47.50 (up ~10%–11%, or ~11%–12% excluding currency); at recent spot rates FX is estimated to be a ~1% benefit to sales and a slight headwind to EPS. For Q3 2026 the company expects local‑currency sales growth of ~4% (including ~0.5% from acquisitions) and adjusted EPS of $12.00–$12.15 (up ~8%–9%, or ~9%–10% excluding currency); currency is expected to be neutral to Q3 sales and a ~1% headwind to Q3 EPS. Additional 2026 assumptions: total amortization ~$78M (purchased intangibles ~$28M pretax, ≈$1.07), interest expense ~$67M, other income ~$24M, effective tax rate ~19%, free cash flow ~ $900M (≈6% growth per share), and share repurchases increased to $875M for the year (vs. $825M annualized in H1).

Mettler-Toledo Risk Analysis

Mettler-Toledo disclosed 29 risk factors in its most recent earnings report. Mettler-Toledo reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Mettler-Toledo Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:MTO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TMOTMO77Outperform$257.71B35.9513.31%0.27%8.27%9.59%
ILMNILMN76Outperform$35.63B38.4731.45%―6.00%31.48%
WATWAT76Outperform$45.46B111.771.88%―52.47%-63.86%
DHRDHR73Outperform$163.38B37.268.18%0.67%5.52%25.53%
AA70Outperform$49.30B33.7920.47%0.59%8.60%19.07%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%50%100%150%DE:MTOADHRILMNTMOWATDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:MTO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:MTOMettler-toledo International1499.00297.0024.71%
AAgilent Technologies171.9927.0018.62%
DHRDanaher Corporation227.9715.717.40%
ILMNIllumina226.58109.7293.89%
TMOThermo Fisher Scientific682.65119.3921.20%
WATWaters Corp449.5382.1922.37%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.